Back to
Wells Fargo & Company
PDSB
Showing 8 of 27 quarters
Position history for
Wells Fargo & Company's holdings in PDS Biotechnology Corporation
Yes. Wells Fargo holds 109,000 shares of PDSB (PDS Biotechnology), worth $96,040, as of its Q2 2026 13F filing. It reduced the position by 1,500 shares (-1.4%) from Q1 2026. Wells Fargo has held PDSB since Q4 2019, across 27 quarterly 13F filings.
Current Value
$96,040
Current Shares
109,000
Total Value Change
+$77,975
Total Shares Change
+104,271
Quarter-by-Quarter History